First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study
Year: 2012
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2010948762
